DC-SIGN/CD209 Antibody (111H2.02) [Alexa Fluor® 647]
Novus Biologicals, part of Bio-Techne | Catalog # DDX0209A647
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Label
Alexa Fluor 647 (Excitation = 650 nm, Emission = 668 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 111H2.02
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
HeLa cells stably transfected-with human DC-SIGN
Reactivity Notes
Human
Marker
Dendritic Cell Marker
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for DC-SIGN/CD209 Antibody (111H2.02) [Alexa Fluor® 647]
Application
Recommended Usage
Flow Cytometry
1:10-1:1000
Immunocytochemistry/ Immunofluorescence
1:10 - 1:500
Application Notes
Flow Cytometry
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Ion exchange chromatography
Formulation
Antibody in Tris-NaCl (pH 8.0)
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C in the dark. Avoid freeze-thaw cycles.
Background: DC-SIGN/CD209
Long Name
Dendritic Cell-specific ICAM-3-grabbing Non-integrin 1
Alternate Names
CD209, CLEC4L, DC-SIGN1, DCSIGN
Gene Symbol
CD209
Additional DC-SIGN/CD209 Products
Product Documents for DC-SIGN/CD209 Antibody (111H2.02) [Alexa Fluor® 647]
Product Specific Notices for DC-SIGN/CD209 Antibody (111H2.02) [Alexa Fluor® 647]
This product is manufactured by Eurobio Scientific (formerly Dendritics) and distributed by Novus Biologicals.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...